Articles with public access mandates - Patricia ZiegelmannLearn more
Not available anywhere: 1
Meta‐analysis of prevalence: I2 statistic and how to deal with heterogeneity
CB Migliavaca, C Stein, V Colpani, TH Barker, PK Ziegelmann, Z Munn, ...
Research synthesis methods 13 (3), 363-367, 2022
Mandates: National Health and Medical Research Council, Australia
Available somewhere: 4
ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores
MS Marcolino, MC Pires, LEF Ramos, RT Silva, LM Oliveira, ...
International Journal of Infectious Diseases 110, 281-308, 2021
Mandates: Government of Spain
Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype
MS Marcolino, KC Meira, NS Guimarães, PP Motta, VS Chagas, ...
BMC Infectious Diseases 22 (1), 639, 2022
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Efficacy of anti-HER2 agents in combination with adjuvant or neoadjuvant chemotherapy for early and locally advanced HER2-positive breast cancer patients: a network meta-analysis
M Debiasi, CA Polanczyk, P Ziegelmann, C Barrios, H Cao, JJ Dignam, ...
Frontiers in Oncology 8, 156, 2018
Mandates: US National Institutes of Health, Susan G. Komen
Background: Several (neo) adjuvant treatments for patients with HER2-positive breast cancer have been compared in different randomized clinical trials. Since it is not feasible …
M Debiasi, CA Polanczyk, P Ziegelmann, C Barrios, H Cao, JJ Dignam, ...
Frontiers in Oncology 8 (156), 1, 2018
Mandates: US National Institutes of Health, Susan G. Komen
Publication and funding information is determined automatically by a computer program